Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
MetaVia Inc.
MTVA
Core
Clinical Trial Result
Other
Form S3 Shelf Registration Disclosure
Other
Market Price Definition
Ipo Net Proceeds Disclosure
Form S3 Shelf Registration Disclosure
Amendment Modification Waiver Clause
Interim Data Positive
Institutional Investment
Use Of Proceeds Disclosure
Warrant Redemption Cashless Exercise Provision
Ipo Or Capital Raising Completion
Warrant Exercise Share Delivery
Core
Clinical Trial Result
Clinical Hold
Lead Asset Progress
Core
Clinical Trial Result
Secondary Endpoint Mentioned
Clinical Hold
Combination Therapy Mentioned
Indication Expansion
Lead Asset Progress
Other
Patient Retention High
Interim Data Positive
Competition Disclosure
Safety Differentiated
Fda Aligned
Publication Positive
Enrollment Ahead Of Schedule
Other
Liquidity Position Snapshot Disclosed
Other
Nasdaq Minimum Bid Price Delisting Notice
Other
Reverse Stock Split Effected
Nyse Listing Disclosure
Form S3 Shelf Registration Disclosure
Fractional Share Cash Payment
Other
Nasdaq Minimum Bid Price Delisting Notice
Core
Clinical Trial Result
Lead Asset Progress
Indication Expansion
Clinical Hold
Combination Therapy Mentioned
Near Term Regulatory Decision
Other
Patient Retention High
Interim Data Positive
Safety Differentiated
Publication Positive
Priority Review Or Pdufa Disclosed
Other
Net Loss Reported
Financing Activities Cash Flow Disclosure
Administrative Efficiency
Personnel Cost Decrease Disclosure
Institutional Investment
Effective Tax Rate Reconciliation
Tax Cuts And Jobs Act Disclosure
Burn Rate Controlled
Ipo Or Capital Raising Completion
Shares Outstanding Disclosure
Other Income Expense Disclosure
Major Tax Law Change Impact
Core
Indication Expansion
Clinical Hold
Business Services
Demand Softening